456 related articles for article (PubMed ID: 31139192)
1. Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD.
Klepsch V; Moschen AR; Tilg H; Baier G; Hermann-Kleiter N
Front Immunol; 2019; 10():1070. PubMed ID: 31139192
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.
Ning L; Lou X; Zhang F; Xu G
Mediators Inflamm; 2019; 2019():2624941. PubMed ID: 30804707
[TBL] [Abstract][Full Text] [Related]
3. Macrophage nuclear receptors: Emerging key players in infectious diseases.
Leopold Wager CM; Arnett E; Schlesinger LS
PLoS Pathog; 2019 Mar; 15(3):e1007585. PubMed ID: 30897154
[TBL] [Abstract][Full Text] [Related]
4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
5. [The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].
Rousseaux C; Desreumaux P
J Soc Biol; 2006; 200(2):121-31. PubMed ID: 17151549
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
[TBL] [Abstract][Full Text] [Related]
7. Ancient Nuclear Receptor VDR With New Functions: Microbiome and Inflammation.
Bakke D; Sun J
Inflamm Bowel Dis; 2018 May; 24(6):1149-1154. PubMed ID: 29718408
[TBL] [Abstract][Full Text] [Related]
8. Interaction of BDE-47 with nuclear receptors (NRs) based on the cytotoxicity: In vitro investigation and molecular interaction.
Song J; Li Y; Zhao C; Zhou Q; Zhang J
Ecotoxicol Environ Saf; 2021 Jan; 208():111390. PubMed ID: 33049448
[TBL] [Abstract][Full Text] [Related]
9. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
10. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.
Stojancevic M; Stankov K; Mikov M
Can J Gastroenterol; 2012 Sep; 26(9):631-7. PubMed ID: 22993736
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia?
Bashashati M; Habibi HR; Keshavarzian A; Schmulson M; Sharkey KA
Curr Drug Targets; 2015; 16(3):199-208. PubMed ID: 25601328
[TBL] [Abstract][Full Text] [Related]
12. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
13. PPAR-γ with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD.
Vetuschi A; Pompili S; Gaudio E; Latella G; Sferra R
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8839-8848. PubMed ID: 30575926
[TBL] [Abstract][Full Text] [Related]
14. Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
Moya M; Gómez-Lechón MJ; Castell JV; Jover R
Chem Biol Interact; 2010 Mar; 184(3):376-87. PubMed ID: 20079722
[TBL] [Abstract][Full Text] [Related]
15. Role of Muscarinic Acetylcholine Receptors in Intestinal Epithelial Homeostasis: Insights for the Treatment of Inflammatory Bowel Disease.
Uwada J; Nakazawa H; Muramatsu I; Masuoka T; Yazawa T
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047478
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Fuchs CD; Traussnigg SA; Trauner M
Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934
[TBL] [Abstract][Full Text] [Related]
17. Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski M; Witkowski M; Gagliani N; Huber S
Semin Immunopathol; 2018 Feb; 40(2):145-156. PubMed ID: 29124320
[TBL] [Abstract][Full Text] [Related]
18. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Yu Y; Yang W; Li Y; Cong Y
Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
Zhao L; Zhang S; He P
Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
